Trial Profile
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms ASSURE
- Sponsors Bristol-Myers Squibb
- 13 Jul 2018 New trial record